4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-046949
Chief Technology Officer sold 20,000 shares at $13.62 ($272,400)
- Chief Technology Officer gave up 772 shares (to pay taxes)
- Chief Technology Officer acquired 1,981 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2022-08-18 | Option exercise | +1,981 | 8,066,396 | D | ||
| Yan Ming Chief Technology Officer | 2022-08-18 | Shares withheld for taxes | −772 | $14.06 | $10,854 | 8,065,624 | D |
| Yan Ming Chief Technology Officer | 2022-08-19 | Sale | −20,000 | $13.62 | $272,400 | 8,045,624 | D |
| Derivatives | |||||||
| Yan Ming Chief Technology Officer | 2022-08-18 | Option exercise · Restricted Stock Units | −1,981 | 27,085 | D | ||
| Open-market sales · 20,000 sh · avg $13.62 · $272,400 | |||||||
Loading xslF345X03/doc4.xml…